Showing results (51-60 of 388) with videos related to
Sort By:
Pageof 39
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patientsTrine Grantzau, Jens OvergaardRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2016
Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patientsTrine Grantzau, Jens OvergaardRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2020
Analysis of cardiac substructure dose in a large, multi-centre danish breast cancer cohort (the DBCG HYPO trial): Trends and predictive modellingRobert Finnegan, Ebbe Laugaard Lorenzen, Jason Dowling, et al.Clinical Epidemiology|April 22, 2025
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus PlaceboSigne Borgquist, Maj-Britt Jensen, Cecilie Linea Bendorff, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2004
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogenMichael R Horsman, Jens OvergaardJournal of Radiation Research|March 18, 2016
The impact of hypoxia and its modification of the outcome of radiotherapyMichael R Horsman, Jens OvergaardThe Lancet. Oncology|June 6, 2003
Does amifostine have a role in chemoradiation treatment?David M Brizel, Jens OvergaardRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 5, 2007
Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 studyJesper Grau Eriksen, Jens Overgaard, Acta Oncologica (Stockholm, Sweden)|June 13, 2003
Evaluation of objective measures of smoking status--a prospective clinical study in a group of head and neck cancer patients treated with radiotherapyJonas Hald, Jens Overgaard, Cai GrauActa Ophthalmologica Scandinavica|September 30, 2004
Have choroidal and ciliary body melanomas changed during the period 1955-2000?Peter Isager, Niels Ehlers, Jens OvergaardPageof 39